Biotia
Company

Last deal

$8M

Amount

Series A

Stage

23.08.2022

Date

3

all rounds

$10.4M

Total amount

date founded

Financing round

General

About Company
Biotia is a health tech startup that diagnoses and controls infectious disease using AI.

Industry

Sector :

Subsector :

Keywords :

founded date

15.01.2016

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Biotia is a health tech startup that provides microbial surveillance to hospitals using DNA shotgun sequencing and artificial intelligence. Their laboratory technology is designed to reduce hospital-acquired infections by identifying and stopping pathogens before patients get sick. Biotia's software enables clinicians and researchers to guide patient treatment and improve health outcomes through rapid and precise infectious disease discovery. The company was spun out of Cornell Tech and leverages next-generation sequencing to offer tailored sequencing solutions for infectious disease diagnosis and control.
Contacts

Contact Email

Website URL

Social url

Similar Companies
1000
MiRXES

MiRXES

MiRXES develops preventive healthcare solutions for cancer, cardiovascular, metabolic, and infectious diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Singapore

total rounds

4

total raised

$218M

count Of Investments

1
Aperiomics

Aperiomics

Aperiomics is revolutionizing infection testing for improved global health.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Sterling, VA, USA

total rounds

6

total raised

$5.2M
Vitality Pandemic Management Cloud

Vitality Pandemic Management Cloud

Eon Biotechnology develops smart medical solutions for infectious disease control.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Software

Location

London, UK
Inherent Biosciences

Inherent Biosciences

Inherent Biosciences is a molecular diagnostics company revolutionizing trial and error medicine, restoring hope.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Artificial Intelligence

Location

Salt Lake City, UT, USA

total rounds

5

total raised

$2.16M

Financials

Funding Rounds
6
3

Number of Funding Rounds

$10.4M

Money Raised

Their latest funding was raised on 23.08.2022. Their latest investor Hyperplane Venture Capital. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
23.08.2022
12
$8M
01.10.2021
1
10.12.2019
3
$2.4M
OCA Ventures

OCA Ventures

Hands-on, collaborative, and entrepreneur friendly early stage VC.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Software, Financial Services

Location

Chicago, IL, USA

count Of Investments

142

count Of Exists

28

Falcon III Ventures

Boston-based biotech venture capital firm, Falcon III Ventures.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Venture Capital, Biotechnology

Location

Boston, MA, USA

count Of Investments

3
Co-Investors
Investors
17
3

Number of lead investors

17

Number of investors

Investor 
Lead 
Round 
Partners 
No
Seed, Series A
No
Series A
No
Series A
Hyperplane Venture Capital

Hyperplane Venture Capital

Hyperplane Venture Capital is a seed stage investment firm focused on exceptional founders building machine intelligence and data companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Boston, MA, USA

count Of Investments

75

count Of Exists

7

Falcon Ventures

Falcon Ventures I is a venture capital fund based in Trenton, New Jersey that primarily invests in technology and manufacturing companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Financial Services, Finance

Location

Trenton, NJ, USA

count Of Investments

2
Sand Hill Angels

Sand Hill Angels

Sand Hill Angels is a Silicon Valley angel investor group dedicated to helping entrepreneurs advance their businesses.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services

Location

Mountain View, CA, USA

count Of Investments

618

count Of Exists

53

People

Founders
4
Rachid Ounit
Rachid Ounit

Rachid Ounit

Dr. Ounit holds a PhD in computer science from the University of California Riverside, a “Diplôme d’Ingénieur” in Computer Science and Management from ENSIIE (France), and a Bachelor in Mathematics & Physics. As an expert in metagenomics, computational biology, artificial intelligence and computer security, his peer-reviewed publications (1,100+ citations) have appeared in top journals: Nature, Genome Biology, PloS Computational Biology and Bioinformatics. Notably, he designed and produced the CLARK tools, an ultra-fast, accurate and scalable system for microorganisms identification from sequencing data, widely adopted by the scientific community (300+ citations). His research work was featured in leading scientific blogs such as Homolog.us., The Molecular Ecologist or Biology News Net, and top news medias tracking innovations in technology and Life sciences such as WIRED, EurekAlert!, Technology.Org, Phys.Org, and GenomeWeb.

current job

Biotia
Biotia

organization founded

1

Rachid Ounit

Christopher Mason
Christopher Mason

Christopher Mason

current job

Cornell University
Cornell University

organization founded

1

Christopher Mason

Chris Mason
Chris Mason

Chris Mason

current job

Onegevity Health
Onegevity Health

organization founded

2

Chris Mason

Niamh O'Hara
Niamh O'Hara

Niamh O'Hara

Niamh O'Hara is the Co-founder and CEO at Biotia. she attended Fordham University.

current job

Biotia
Biotia

organization founded

1

Niamh O'Hara

Employee Profiles
3
Rachid Ounit

Rachid Ounit

Co-Founder and CTO

Chris Mason

Chris Mason

Co-Founder

Niamh O'Hara

Niamh O'Hara

Co-founder and CEO

Activity

Recent News
0